A Study to Assess the Adverse Events and How Intravenously Infused Livmoniplimab in Combination With Budigalimab Moves Through the Bodies of Adult Chinese Participants With Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC)
Clinical trial NCT06487559 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06487559
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-11
- Primary completion
- 2027-02-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.